Medical/Pharmaceuticals

2025 AACR | Innovent Presents Preclinical Data of Multiple Novel Molecules including Bispecific and Tri-specific Antibodies and Bispecific ADCs

SAN FRANCISCO and SUZHOU, China, April 28, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmun...

2025-04-28 08:00 1745

Everest Medicines Announces the "B" Marker Removal from Company's Stock Code, Effective May 2, 2025

SHANGHAI, April 28, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that the "B" marker will cease to be...

2025-04-28 07:30 2063

Antengene Presents Four Posters at AACR 2025 Highlighting Focuses on AnTenGagerTM TCEs and Synthetic Lethality

SHANGHAI and HONG KONG, April 26, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hem...

2025-04-26 08:30 3824

Innovent Announces NMPA Approval of Limertinib, a Third-generation EGFR TKI Collaborated with ASK Pharma, for the First-line Treatment of Lung Cancer

SAN FRANCISCO and SUZHOU,China, April 26, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metaboli...

2025-04-26 08:00 5508

Gleneagles Hospital Penang Introduces Southeast Asia's First SOMATOM Pro.Pulse Dual Source CT Scanner

KUALA LUMPUR, April 25, 2025 /PRNewswire/ -- Gleneagles Hospital Penang today launched the new SOMATOM Pro.Pulse Computed Tomography (CT) Scanner, the very first of its kind inSoutheast Asia. This cutting-edge technology enables faster, more accurate diagnostics - supporting better treatment deci...

2025-04-25 18:19 10955

Sanofi and Sobi extend their partnership with the World Federation of Hemophilia Humanitarian Aid Program

* Up to five-year contract extension to support the WFH Humanitarian Aid Program with medicine donations and financial assistance MONTREAL, April 25, 2025 /PRNewswire/ -- The World Federation of Hemophilia (WFH) and WFH USA, together with Sanofi, through its philanthropic organization Foundatio...

2025-04-25 12:01 2354

A Visionary Breakthrough: VISTA Eye Specialist and EssilorLuxottica Join Forces to Combat Childhood Myopia in Malaysia

PETALING JAYA, Malaysia, April 25, 2025 /PRNewswire/ -- In a landmark move to safeguard the vision ofMalaysia's future generation, VISTA Eye Specialist ('VISTA'), the nation's trusted eye care brand, announced a strategic collaborationMemorandum of Understanding (MoU) with EssilorLuxottica, the ...

2025-04-25 08:00 2852

Sengkang General Hospital Introduces Siemens Healthineers Photon-Counting CT Scanner to Advance Diagnostic Capabilities

* New photon-counting CT scanner aims to enhance diagnostic imaging capabilities for SKH. * Advanced technology provides clearer images with lower radiation dose, improving diagnostic precision and patient safety. SINGAPORE, April 24, 2025 /PRNewswire/ --Sengkang General Hospital (SKH) offici...

2025-04-24 18:57 2818

SWS Medical and Hemotek - Partners in Innovations at the 45th Philippine Society of Nephrology Annual Convention

MANILA, Philippines, April 24, 2025 /PRNewswire/ -- SWS Medical, a leading Chinese blood purification provider, is excited to participate in the 45th Philippine Society of Nephrology Annual Convention (April 24-26, 2025 Preferred Booth 1),the Philippines' largest nephrology academic event. In par...

2025-04-24 14:57 2751

Kelun-Biotech to Present Results of Six Clinical Studies at 2025 ASCO Annual Meeting

CHENGDU, China, April 24, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) announced that it will present results from six Kelun-led clinical studies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held inChicago from May 30 to June 3. Resu...

2025-04-24 13:17 2379

Antengene to Present Latest Results From Two Clinical Studies at ASCO 2025

SHANGHAI and HONG KONG, April 24, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hem...

2025-04-24 10:26 2620

2025 Medtec Free Pre-Registration Kicks Off! Meet Over 1000 Chinese Local Enterprises

SHANGHAI, April 24, 2025 /PRNewswire/ -- The 2025 Medtec International Medical Device Design & Manufacturing Technology Exhibition (hereinafter referred to as 2025 Medtec) will be held at the Halls 1&2 of Shanghai World Expo Exhibition & Convention Center fromSeptember 24 to September 26. This ex...

2025-04-24 09:00 1244

Seven Oral Presentations: Innovent to Present Breakthrough Clinical Data of IBI363(PD-1/IL-2α-bias)and Other Novel Drug Candidates at the 2025 ASCO Annual Meeting

SAN FRANCISCO and SUZHOU,China, April 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune...

2025-04-24 07:00 3658

FIELD MEDICAL ANNOUNCES FIRST-IN-HUMAN DATA FOR FOCAL PFA IN SCAR-RELATED VT AT HEART RHYTHM 2025

Eight presentations, including late-breaking science, live cases, and a landmark symposium CARDIFF-BY-THE-SEA, Calif., April 23, 2025 /PRNewswire/ -- Field Medical Inc., a leader in cardiac pulsed field ablation (PFA) technology, announced today its FieldForce™ Ablation System will be featured i...

2025-04-23 20:33 2697

Clarivate Launches DRG Commercial Analytics 360 Enabling Medtech Companies to Advance Commercial Strategy and Execution

New solution provides integrated provider intelligence and real-world data to optimize targeting, strategic planning and patient access across commercial organizations LONDON, April 23, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, tod...

2025-04-23 16:00 2321

United Imaging and IHH Healthcare Forge Strategic Partnership to Enhance Global Access to Advanced Imaging Technologies

SHANGHAI, April 23, 2025 /PRNewswire/ -- April 10, 2025, United Imaging, a global leader in medical imaging and radiotherapy equipment, has signed a memorandum of understanding (MOU) with IHH Healthcare, a world-leading integrated healthcare provider. The agreement, announced during the China In...

2025-04-23 13:26 3046

GenScript Biotech and NSG Bio Form Strategic Partnership to Drive Biotechnology Innovation

SINGAPORE, April 23, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in biotechnology research services, and NSG Bio,Singapore's premier biotech incubator, today announced a strategic partnership designed to accelerate innovation and growth within the biotechnology sector. <...

2025-04-23 10:00 2860

Investment of Approx. USD 4.5 Million in Development of Diagnostics for Tuberculosis to Partners Including Fujirebio and University Hospital Heidelberg

TOKYO, April 23, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximatelyJPY 679 million (USD 4.5 million1) for the development of diagnostics for tuberculosis, in addition to an investment of approximatelyJPY 15.9 million (USD 0.1 mi...

2025-04-23 09:00 2176

Ascletis Announces Positive Topline Results of U.S. Phase Ib Multiple Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Submission of 13-week Phase IIa Study Protocol to FDA

- ASC30 oral once-daily tablet demonstrated a 6.5% placebo-adjusted mean body weight reduction from baseline after four-week treatment using weekly doses with titrations of 2 mg, 10 mg, 20 mg, and 40 mg doses. - ASC30 oral once-daily tablet also demonstrated a 4.5% placebo-adjusted mean body we...

2025-04-23 07:30 2694

Getinge Interim Report January-March 2025: Strong sales and improved earnings - continued focus on customer value and profitability going forward

GOTHENBURG, Sweden, April 22, 2025 /PRNewswire/ -- "We are entering 2025 with healthy organic sales growth and improved adjusted operating profit despite headwinds from currency effects," says Mattias Perjos, President & CEO at Getinge. The medtech company's net sales increased organically by 6.2...

2025-04-22 20:38 2573
1 ... 56575859606162 ... 395